12th Annual Outsourcing in Clinical Trials Nordics 2024

The annual meeting place for pharmaceutical, biotechnology, and medical device communities in the Nordics to network and discuss strategies for operational success in clinical trials

1 - 2

October

2024
  • Clarion Hotel & Congress Copenhagen Airport, Denmark
  • Complimentary
  • Why attend?
  • Agenda
  • OCT Advisory Board
  • Speakers
  • Plan Your Visit
  • Event Gallery
  • Sponsors
  • Media Centre
  • Why partner?
  • Contact Us
close

Why attend?

WHAT TO EXPECT FOR 2024?

200+

Attendees

30+

Exhibitors

30+

Speakers

200+

Attendees

30+

Exhibitors

30+

Speakers

See What It's All About

Agenda

  • 1 Oct 2024
  • 2 Oct 2024
Expand All

Streams

Stream one

OUTSOURCING IN CLINICAL TRIALS & CLINICAL OPERATIONS

7:30 AM

Registration and refreshments

8:15 AM

Chairperson’s opening remarks

Speakers

Helen Johansen Blanco
Chief Operating Officer, Node Pharma A/S

8:30 AM

Sharing latest updates to the Clinical Trial Regulation (CTR) and Clinical Trial Information System (CTIS)

• Providing latest updates: what’s new from the EU regulatory framework?
• Learning from previous submissions: tips and tricks

Speakers

Lene Grejs Petersen
Senior Advisor, Danish Medicines Agency

9 AM

A new paradigm for clinical innovation

The clinical research industry is at an inflection point. Advancements in technology have created the opportunity to transform clinical trial outcomes, but to make this ambition a reality, we must now rethink how we engage with patients.

Today, we often treat patient relationships as transactional, de-identified numbers on individual clinical trials. We need a new way of thinking about patients. A more longitudinal way, with greater pre-trial engagement and post-trial follow-up, and across multiple studies and healthcare experiences.

We also need to change how we look at patient data, widening the lens to understand patients’ health and research journeys across a broad ecosystem of data sources. But how do we execute this paradigm shift when we’re also under pressure to accelerate timelines, reduce risk, lower costs, and improve quality?

In this presentation, we’ll explore:

  • Industry drivers of this clinical research evolution
  • Challenges faced & the value of change
  • Reasons to believe - Improving trial experiences for patients, sites, CROs, & sponsors

Speakers

Richard Gray
Managing Partner, Medidata, Dassault Systemes

9:30 AM

Building an Outsourcing Strategy for your clinical trials

• Initiation: landscaping and defining the project
• Strategy development: analyses and stakeholder management
• Implementation: selecting vendors, training and alignment
• Maintenance: KPIs and governance
• Tips and tricks to consider

Speakers

Rikke Winther
Outsourcing Specialist, Camurus AB

Streams

Stream one

OUTSOURCING IN CLINICAL TRIALS & CLINICAL OPERATIONS

Stream two

CLINICAL TRIALS TECHNOLOGY & INNOVATION

8:15 AM

Registration and refreshments

8:45 AM

Chairperson’s Opening Remarks

Speakers

Helen Johansen Blanco
Chief Operating Officer, Node Pharma A/S

9 AM

Navigating through the jungle of regulatory requirements for combination trials

  • Overview of the COMBINE project created to analyse challenges and find solutions for combined studies
  • Reviewing key regulatory factors within CTR, MDR and IVD to ensure compliance
  • Best practice for streamlining your submissions to optimise approvals for parallel submissions

Speakers

Ditte Zerlang Andersen
Senior EU Project Lead, Senior Adviser, Danish Medicines Agency

9:30 AM

Asia Pacific clinical trials: opportunities and regulatory updates

  • Advantages in running clinical trials in the APAC region
  • Key country differences and regulatory updates
  • How to overcome challenges to ensure clinical trial success

Speakers

Kento Nakamura
Strategy and Corporate Development, CMIC

10 AM

Improving sustainability: Healthcare transition into a Net Zero world

  • Healthcare sector’s responsibility and action to address the climate crisis as accelerator for the health crisis
  • Clinical best-practices to save significant natural and financial resources
  • Progress to date and influencing sourcing services

Speakers

Morten Pedersen
VP, Head of Clinical Operations, Lundbeck

10:30 AM

Morning Refreshments & Networking

11 AM

Re-evaluating your study if things go wrong in clinical trial: to stay or change?

  • Pro-actively preparing for the worst up front
  • Considerations for changing or re-assessing sites
  • Assessing, selecting and switching vendors: benefits and challenges
  • Case study example: success and lessons learnt

Speakers

Helen Johansen Blanco
Chief Operating Officer, Node Pharma A/S

11:30 AM

Reimagining clinical trials: Boosting efficiency with simplified, low-code builds

  • In clinical trials where approval is always tomorrow and go-live is yesterday, use of innovative technology is critical to saving time and boosting efficiency but doesn't have to
    introduce complexity
  • A simplified study build process relies on reuse such as pre-made form libraries and duplication of previous studies
  • Time reductions in study build can be unlocked with intuitive tools that impact learning curve and process time
  • Low-code / No-code approach to study build can offer complex study builds without reliance on complex or proprietary programming languages
  • Sharing key documentation can further improve efficiency across clinical staff and subjects such as signature collection, patient engagement and digital incentives that lead to improved adherence rates

Speakers

Lina Gaggi
Product Manager, Viedoc

12 PM

Implementing decentralised clinical trial (DCT) elements: a sponsor experience

  • Reviewing current state and future direction of decentralized clinical trials post-COVID-19 through sponsor survey results
  • Providing greater understanding of innovative modern solutions that could help support more effective patient engagement and choice
  • Discussing best practices and barriers experienced when implementing DCT elements as part of global trials
  • Sharing learnings to inform of modern patient centric ways of working for industry and regulators and available tools to support this

Speakers

Joachim Lovin
DCT Specialist, Novo Nordisk

12:30 PM

Lunch and networking

1:30 PM

PI overview of patient safety when carrying out digital elements and decentralized clinical trials

  • Outlining role of the Principal Investigator in digital and decentralized clinical trials
  • Considering key strategies for ensuring patient safety and maintaining regulatory compliance
  • Sharing examples of benefits and challenges of digital integration

Speakers

John Zibert
Chief Medical Officer, Coegin Pharma

2 PM

Fireside Chat: How to de-risk a clinical development program?

  • Value of obtaining early feedback from Key Opinion Leaders and Regulators
  • Risk assessment at the trial level
  • Trial oversight matrix implemented with all vendors and subcontractors

Speakers

Anna Polak-Andersen
Head of Clinical Development, Entero Target

2:30 PM

Afternoon refreshments, networking and prize draw

3 PM

ROUNDTABLE SESSIONS

During the roundtable discussion session, the conference hall will be divided into zones. Delegates can choose which zone they would like to join. Each zone will be led by a table moderator and will focus on a different challenge within the industry. After 30 minutes, delegates will have the opportunity to swap and choose a different table, and each roundtable will run twice.

Roundtable 1
Mitigating risk in clinical supply chain
Pernille Hemmingsen, Chief Technology Officer, Adcendo

Roundtable 2
Engaging with CROs: defining deliverables and agreements
Asger Dahlgaard, VP of Quality Assurance and Regulatory Affairs, BioPorto Diagnostics A/S

Roundtable 3
Considering DCT trial design and impact on both the patient and company
John Zibert, Chief Medical Officer, Coegin Pharma

Speakers

Pernille Hemmingsen
Chief Technology Officer, Adcendo
Asger Dahlgaard
VP of Quality Assurance and Regulatory Affairs, BioPorto Diagnostics A/S
John Zibert
Chief Medical Officer, Coegin Pharma

4 PM

End of conference

8:45 AM

Chairperson’s opening remarks

Speakers

Libbi Rickenbacher
Senior Director Product Strategy and Partnerships, 4G Clinical

9 AM

Case Study: Real world example of Artificial Intelligence in clinical development – PoC to Production

  • Understanding regulation and preparing compliance
  • Driving innovation and technology into processes through use of generative AI
  • Implementing AI for practical use with valuable return on investment

Speakers

Stephen Lutsch
Senior Director Clinical Trial Digital Innovation, Genmab

9:30 AM

AI in Risk Based (Quality) Monitoring

Regulatory bodies are promoting Risk Based (Quality) Monitoring as a best practice in clinical trials to correct data quality issues as early as possible in the trial lifecycle. Since this involves the identification of specific patterns in large datasets, artificial intelligence can support us in doing this efficiently.

  • How can AI find specific patterns that humans might miss
  • Interactions between AI and humans in RB(Q)M
  • Real life examples in respiratory

Speakers

Benoit Cuyvers
Upstream AI Product Manager, Clario

10 AM

Case Study: Accelerating innovation through digital health technology solutions

  • Driving true benefits for clinical research through digital health technology
  • Learnings from barriers created by integration of digital health
  • Improving processes and focusing on delivering digital health as a tool

Speakers

Magnus Jörntén-Karlsson
Head of Digital Patient & Site Technology, Evinova at AstraZeneca

10:30 AM

Morning Refreshments & Networking

11 AM

Expert Conversation: Strategic Considerations for End-to-End Development of Fit-For-Purpose Digital Measures of Health

  • Strategies for sourcing components from a scattered ecosystem
  • How to develop meaningful, human-centric measures
  • Pitfalls and opportunities for analytical and clinical validation
  • Novel solutions and digital pathways for scalable regulatory qualification
  • Maximizing value: how to repurpose and extend solutions across use cases in R&D and healthcare

Speakers

Kai Langel
CEO, DEEP Measures
Teske Valk
Lead Medical Project Manager, Novo Nordisk

11:30 AM

The new age of R&D procurement: clinical business operations transformed

  • We will examine the high cost of doing nothing
  • What is the status quo and can technology help?
  • Vendor management - tackling one of the biggest challenges
  • The role that AI can play
  • What you can gain by embracing technology

Speakers

Anca Copaescu
Chief Executive Officer, Strategikon Pharma

12 PM

Transforming clinical trials: ideas from leading industry professionals

  • Assessing outcomes from over 70 interviews with life science industry pioneers
  • Reviewing what clinical professionals wish would be different in the life sciences industry
  • Suggesting next steps towards further evolving clinical trials

Speakers

Ivanna Rosendal
Senior Director, IT Business Partner, Ascendis Pharma

12:30 PM

Lunch and networking

1:30 PM

Maintaining control and oversight of data in outsourced trials

  • Considering, generally and specifically, data collected with eDiary, CGM and other external sources
  • Assessing risks when outsourcing trials
  • Acting accordingly to manage and mitigate risks
  • Maintaining right level of oversight

Speakers

Ane Jensen
Principal Data Manager, Zealand Pharma

2 PM

Panel Discussion: Considering existing and emerging technology to assist with clinical trials

  • Digitalization: what can we digitalize to improve systems and processes
  • AI: what can we implement to save time and resource
  • Systems: what technology and systems are available and emerging to assist in clinical trials and data management

 

Speakers

Libbi Rickenbacher
Senior Director Product Strategy and Partnerships, 4G Clinical
Stephen Lutsch
Senior Director Clinical Trial Digital Innovation, Genmab
Ane Jensen
Principal Data Manager, Zealand Pharma
Richard Gray
Managing Partner, Medidata, Dassault Systemes

2:30 PM

Afternoon refreshments, networking and prize draw

10 AM

Protocol optimization: How a transformational relationship with your CRO can increase your development programs’ chances of success

  • Maximizing the opportunity for strategic input and design feedback from your CRO throughout the outsourcing process
  • Overview of the typical areas where your CRO can guide and facilitate study optimization
  • Examples of where CRO experience has transformed study design and operations, to sponsor advantage

Speakers

Rich Bennett
Senior Director, Therapeutic Strategy Lead, Neuroscience, Worldwide Clinical Trials

10:30 AM

Morning Refreshments & Networking

11 AM

Building CRO Relationships: What are the critical factors to consider when procuring from a CRO?

  • Establishing common ground with your CRO
  • Ascertaining the critical factors to think about when you collaborate with a CRO
  • Exploring how the concept of co-development between Pharma & CRO is working best
  • Overcoming the differences between Pharma & CRO business models to work in harmony
  • Underlining the factors which could be limiting what choice you make?

Speakers

Stine Friis Thorsen
Project Director, Evaxion Biotech

11:30 AM

Why so slow? Insider insights from the clinic floor to speed up the startup and execution of proof-of-concept patient trials

How to:

  • Harness regulatory dynamics for strategic advantages.
  • Obtain feasibility figures true to delivery.
  • Employ innovative study designs to expedite the development program.
  • Customize efficient patient recruitment tactics!

Speakers

Dr. Claudia Hesselmann
Founder and CEO, ARENSIA Exploratory Medicine

12 PM

Panel Discussion: Defining effective governance structures and oversight models

  • Creating an efficient governance structure to suit the study
  • Communicating and monitoring the framework
  • Evaluating needs and wants of both sponsor and vendor companies
  • Sharing best practice for governance oversight

Speakers

Helen Johansen Blanco
Chief Operating Officer, Node Pharma A/S
Caroline Sandstroem
Head of Global Clinical Quality, Ferring Pharmaceuticals
Anna Polak-Andersen
Head of Clinical Development, Entero Target
Lien Verheggen
Head of Clinical Operations. Estetra (a wholly owned subsidiary of Gedeon Richter Plc)
Sara Thuresson
Head of Clinical Operations, Guard Therapeutics

12:30 PM

Lessons in chemistry: The art of site engagement

Clinical trials follow a formula, but their success is about more than science. How can sponsors maximise their communications opportunities to stimulate and maintain the passion and proactivity that are key to the success of their study, among site staff with competing priorities, who may feel they’ve seen it all before

Speakers

Chloe Gower-Page
Senior Account Director, Site Engagement, Clinical Trial Experience, Langland

1 PM

Lunch and networking

2 PM

Clinical trial outsourcing: a customer perspective

  • Clinical trial outsourcing strategies
  • Sponsor company expectations and CRO selection
  • Clinical trial oversight – considerations for finding the right balance between efficiency and safety

Speakers

Christopher Burton
Chief Medical Officer, Reponex Pharmaceuticals A/S

2:30 PM

Ensuring success: Essential sponsor oversight strategies for confirming your clinical study is on track

  • Why it is so important to have proper oversight over study conduct
  • How to make it smooth and effective
  • Which aspects of the trial should have your special attention
  • How CRO can support with keeping oversight on the proper level

Speakers

Monika Martyka
Director Clinical Operations, TFS HealthScience

3 PM

Clinical Trial Investigations: Looking at the trends and landscape for 2023 and what we can learn from them

  • Overview of global clinical trials for 2023
  • Assessing key sponsors, top interventions and looking at the trial landscape for 2023
  • Looking at key obstacles for terminated trials and evaluation of completed trials which have achieved endpoint status

Speakers

Priya Ravisekara
Senior Analyst, GlobalData

3:30 PM

Afternoon refreshments and networking

4 PM

Developing neuroimaging and CNS drug: preparing for clinical trial

  • Sharing insights on collaborations with clinical CROs on previous clinical studies
  • Preparing for a clinical trial with a University Hospital in Denmark
  • Choosing and developing the right trial design

Speakers

Christine Ryan
Chief Operating Officer, Gabather

4:30 PM

Empowering patients to overcome challenges in orphan drug development

  • Orphan drug market: Illustrate the unique challenges of developing a drug for rare diseases
  • Patient-focused drug development: Designing patient-centered clinical trials
  • Operational considerations: Endpoint selection; reducing the burden of participation; cost; sites; patient concierge services
  • Collaboration: Focus on the need for collaboration in this space: sponsors, CRO (Clinical Research Organizations), patients, patient advocacy groups, investigators, vendors

Speakers

Scott Schliebner
Vice President Drug Development Consulting, Novotech

5 PM

Panel Discussion: Focusing on the patient: diversity, engagement and safety

  • Increasing patient engagement and involvement
  • Improving diversity in clinical trials
  • Considering sites and patient safety

Speakers

Helen Johansen Blanco
Chief Operating Officer, Node Pharma A/S
Révérien Uwacu
Clinical Trial Supply Management Consultant at UCB
Dr. Claudia Hesselmann
Founder and CEO, ARENSIA Exploratory Medicine
John Zibert
Chief Medical Officer, Coegin Pharma

5:30 PM

Chairperson’s closing remarks

Speakers

Helen Johansen Blanco
Chief Operating Officer, Node Pharma A/S

END OF DAY 1 AND NETWORKING DRINKS SPONSORED BY FORTREA

Speakers

Select a speaker to learn more

Back
Ivanna Rosendal
Senior Director, IT Business Partner, Ascendis Pharma

Session Details:

Transforming clinical trials: ideas from leading industry professionals

2024-10-02, 12:00 PM

View In Agenda

Social Links:

Next speaker
Back
Magnus Jörntén-Karlsson
Head of Digital Patient & Site Technology, Evinova at AstraZeneca

Session Details:

Case Study: Accelerating innovation through digital health technology solutions

2024-10-02, 10:00 AM

View In Agenda
Next speaker
Back
Rikke Winther
Outsourcing Specialist, Camurus AB

Rikke Winther has worked in the CRO and Pharmaceutical industry for the past 30 years and has experience from Clinical R&D, Business Development and Contract/Outsourcing Management. She built up and headed up Lundbeck group of Outsourcing & Contracts Management R&D for 19 years and has for the past 5 years worked as an clinical outsourcing specialist for smaller biopharma and covers CRO selection processes as well as contractual, operational and relationship related activities with clinical CROs.

She has in earlier part of her career within bio-analytical research and clinical development in hospital settings as well as project management and business development management at a clinical CRO in Europe and Asia.

Rikke is a former member of the Steering Committee member of the Pharmaceutical Contract Management Group (PCMG) for many years and is a contributing author of the book: “Outsourcing Clinical Development, Gower Publishing Limited”.

 

Session Details:

Building an Outsourcing Strategy for your clinical trials

2024-10-01, 9:30 AM

View In Agenda
Next speaker
Back
John Zibert
Chief Medical Officer, Coegin Pharma

Dr. John Zibert, Chief Medical Officer Coegin Pharma AB, a listed Nordic biotech company with several unique molecular technologies and compounds , where he also serves as CEO of Avexxin Oncology AS and Board Member of Reccura Therapeutics AS. He received his master's in medicine and human biology, and PhD in immunology at the University of Copenhagen, DK and University of Otago, NZ. He has demonstrated a successful history of working in the pharmaceutical and digital healthcare industry in established corporate businesses, and in an incubator co-establishing more than 25 start-ups within digital health and biotech, and several of his own biotech companies. Furthermore, he has an academic footprint of 79 publications in particular within digital health, tumor biology and dermatology. He has a deep experience within execution of drug research and development, Decentralized Clinical Trials, digital healthcare solutions, and leadership.

Session Details:

Panel Discussion: Focusing on the patient: diversity, engagement and safety

2024-10-01, 5:00 PM

Session Details:

ROUNDTABLE SESSIONS

2024-10-02, 3:00 PM

Session Details:

PI overview of patient safety when carrying out digital elements and decentralized clinical trials

2024-10-02, 1:30 PM

View In Agenda
Next speaker
Back
Lene Grejs Petersen
Senior Advisor, Danish Medicines Agency

Lene Grejs Petersen is Senior Adviser at the Danish Medicines Agency, Clinical Trial Unit. Lene is member of the Clinical Trials Coordinating and Facilitation Group (CTCG) member since 2008 and is the Danish representative Clinical Trials Advisory Group (CTAG) since 2022. Lene has been an employee at the Danish Medicines Agency since 2000 and she has been involved in the implementation of the EU Clinical Trials Regulation and works as a regulatory assessor and coordinator of clinical trials. Lene has a background as Master in Pharmacy.

Session Details:

Sharing latest updates to the Clinical Trial Regulation (CTR) and Clinical Trial Information System (CTIS)

2024-10-01, 8:30 AM

View In Agenda
Next speaker
Back
Ditte Zerlang Andersen
Senior EU Project Lead, Senior Adviser, Danish Medicines Agency

Ditte Zerlang Andersen joined the Danish Medicines Agency (DKMA) in 2015 as a clinical trial assessor. She now leads strategic projects in our national and EU regulatory landscape as a senior strategy project lead. Ditte recently led the work of the EU ‘COMBINE’ project analysing the interface between clinical trials and the device and in vitro diagnostic area. Prior joining DKMA, Ditte worked 5 years in the pharmaceutical industry and have a PhD in neuroscience.

Session Details:

Navigating through the jungle of regulatory requirements for combination trials

2024-10-02, 9:00 AM

View In Agenda
Next speaker
Back
Caroline Sandstroem
Head of Global Clinical Quality, Ferring Pharmaceuticals

Dr. Caroline Sandström received her PhD in Medical Science from Lund University, Sweden in 2008. She has then worked for Novo Nordisk A/S, Denmark for several years as a pharmacologist driving and executing pharmacological plans supporting pre-clinical projects.

Her interest and enthusiasm for project management, continuous improvement, streamlining initiatives and training was then later beneficially used when she moved into the compliance area managing global improvement and training initiatives within R&D Quality Management System (QMS) including Clinical. For example, she was the project manager for implementing the effective use of Root Cause Analysis in Clinical Development activities but also being highly involved in initiatives related to Quality Culture.  Ferring Pharmaceuticals A/S in Copenhagen, DK. On a daily basis she was involved in discussing, driving compliance and improvement initiatives within both Non-Clinical, Clinical and Pharmacovigilance related activities. She has taken a very active role in contributing to a collaborative and transparent organization where sharing learnings are a main focus area.

From beginning of May 2022, she moved into the position of being Head of the Global Clinical Quality Department being responsible for the QA support of global key stakeholder areas such as Clinical Development, Regulatory Affairs, Pharmacovigilance and Discovery. Her scientifically driven problem-solving skills are used for implementing global cross-functional initiatives, and for supporting and strengthening the harmonization and quality mindset in the organization.

Session Details:

Panel Discussion: Defining effective governance structures and oversight models

2024-10-01, 12:00 PM

View In Agenda
Next speaker
Back
Christine Ryan
Chief Operating Officer, Gabather

Dr Christine Natasha Ryan holds a PhD in Neuroscience from the University of Cambridge, Cambridge, UK and an MBA from Stockholm School of Economics. Following a post-doc at the Brain Research Institute, St. Hans Hospital, Roskilde, Denmark, Dr Ryan remained in Scandinavia moving to Sweden to work at Astra, which then became AstraZeneca, holding line management and competitive intelligence roles. Dr Ryan has engaged in preclinical research at blue chip companies such as AstraZeneca, smaller pharmaceutical companies, CROs and biotechs, working at Karo Bio AB, and Cerca Insights among others. Dr Ryan joined Gabather AB as Principal Scientist in 2017, becoming VP Operations in 2018. She is currently COO.

Session Details:

Developing neuroimaging and CNS drug: preparing for clinical trial

2024-10-01, 4:00 PM

View In Agenda
Next speaker
Back
Stephen Lutsch
Senior Director Clinical Trial Digital Innovation, Genmab

In my position as Senior Director - Clinical Trial Digital Innovation at Genmab, I lead a team driving AI adoption within clinical operations, decentralized clinical trials and digital innovation in drug development. Previously, I have been working to bring the best disruptive innovation into normal clinical operations at LEO Pharma to help improve and accelerate their clinical trials. Furthermore, I am trying to solve some of the toughest challenges related to scaling digitalization, data, and automation to generate competitive advantages across business units. One aspect is driving the necessary foundational components around a scalable GxP data platform, machine learning opportunities as well as automating digital processes with robotics process automation. Besides leading the necessary change internally, focus is on a design-thinking approach where we put the patient and site at the center. I have an ambition towards “delighting” patients, investigators, and sponsors by solving the real-world challenges they face by leveraging both qualitative interviews and observation, as well as quantitative methods to reveal actionable insights

Session Details:

Case Study: Real world example of Artificial Intelligence in clinical development – PoC to Production

2024-10-02, 9:00 AM

Session Details:

Panel Discussion: Considering existing and emerging technology to assist with clinical trials

2024-10-02, 2:00 PM

View In Agenda
Next speaker
Back
Priya Ravisekara
Senior Analyst, GlobalData

Priya Ravisekara, MSc,is a senior analyst at GlobalData in London, UK, where her primary responsibilities include producing analytical reports, improving and maintaining database functionality through quality assurance testing, updating and monitoring Global Data’s Clinical Trials Intelligence Database, and answering queries directly from clients. Priya holds a Masters in Clinical Drug Development from Barts and The London School of Medicine and Dentistry, and a Bachelor of Science in Biochemistry from Brunel University, London.​

Session Details:

Clinical Trial Investigations: Looking at the trends and landscape for 2023 and what we can learn from them

2024-10-01, 3:00 PM

View In Agenda
Next speaker
Back
Morten Pedersen
VP, Head of Clinical Operations, Lundbeck

Morten completed his Master’s degree in Biotechnology at National University of Ireland, Galway, in 1997, specializing in Pharmacology. He joined Lundbeck in August 2020 as VP, Head of Clinical Operations.

Career to date Morten started at a CRO in 1997 as a CRA on an Epilepsy study.  In the subsequent years he worked in CRO’s, consultancy and big Pharma taking on roles within Project Management, Program Oversight, Innovation and Strategic Partnerships.  He joined Pfizer in 2003 and has a wide range of project management experience delivering projects across multiple therapeutic areas. From 2007 to 2011 he held a leadership role in Pfizer’s Clinical Study Management group providing Operational Oversight in various outsourcing models.  As Group Lead of Emerging Markets and Established Products Business Units he managed a team of Program Directors in a variety of Therapy Areas from Phase II to Late Phase and Non-Interventional trials. From late 2011 Morten joined an Innovation technology CRO in the role of Senior Director and Head of Strategic Partnerships with the aim of improving Clinical Trial efficiencies and supporting Trial Sites. In August 2016 he joined InVentiv Health as VP, Head of Program Delivery in Neuroscience, before the group merged with INC to become Syneos Health.

 

Session Details:

Improving sustainability: Healthcare transition into a Net Zero world

2024-10-02, 10:00 AM

View In Agenda
Next speaker
Back
Helen Johansen Blanco
Chief Operating Officer, Node Pharma A/S

Helén Johansen Blanco has 24 years of clinical development experience, managing Phase I to III clinical trials leading to the successful launch of several oncology products, as Revlimid, Xofigo and a Herceptin biosimilar. She has experience in project management and financial oversight of large global clinical trials conducted in all continents of the world, mainly within oncology, but also therapeutic areas as cardiovascular and gastrointestinal. Mrs. Blanco has previously worked for large international pharma companies such as AstraZeneca and Mylan, as well as small, medium to large sized biotechnology companies as Nordic Nanovector, Oncoinvent, Cantargia, Cytovation and Celgene. Currently she holds a position as Chief Operating Officer at Node Pharma AS, a small medium sized Norwegian biotech company. She holds a Diploma Engineer/MSc degree in Biophysics and medical technology and a MBA.

Session Details:

Chairperson’s Opening Remarks

2024-10-02, 8:45 AM

Session Details:

Panel Discussion: Focusing on the patient: diversity, engagement and safety

2024-10-01, 5:00 PM

Session Details:

Chairperson’s closing remarks

2024-10-01, 5:30 PM

Session Details:

Re-evaluating your study if things go wrong in clinical trial: to stay or change?

2024-10-02, 11:00 AM

Session Details:

Panel Discussion: Defining effective governance structures and oversight models

2024-10-01, 12:00 PM

View In Agenda
Next speaker
Back
Christopher Burton
Chief Medical Officer, Reponex Pharmaceuticals A/S

Session Details:

Clinical trial outsourcing: a customer perspective

2024-10-01, 2:00 PM

View In Agenda
Next speaker
Back
Ane Jensen
Principal Data Manager, Zealand Pharma

Ane H. Jensen (MA)

Passionate about new technology and their ability to change the way we conduct clinical trials. Has worked at different positions in Novo Nordisk between 2008 and 2020. Since 2020 employed at Zealand Pharma. Previous experiences include RTSM, training, process improvements, logistics, clinical trials supplies and eLearning development.

Session Details:

Maintaining control and oversight of data in outsourced trials

2024-10-02, 1:30 PM

Session Details:

Panel Discussion: Considering existing and emerging technology to assist with clinical trials

2024-10-02, 2:00 PM

View In Agenda
Next speaker
Back
Anna Polak-Andersen
Head of Clinical Development, Entero Target

Session Details:

Panel Discussion: Defining effective governance structures and oversight models

2024-10-01, 12:00 PM

Session Details:

Fireside Chat: How to de-risk a clinical development program?

2024-10-02, 2:00 PM

View In Agenda
Next speaker
Back
Dr. Claudia Hesselmann
Founder and CEO, ARENSIA Exploratory Medicine

Dr. Claudia Hesselmann, a chemist by training, with a PhD in molecular biology. Claudia has twenty years of expertise in the early phases of drug development. Her experience includes co-founding and holding management positions in various CROs. Her extensive background and social acumen, along with her first-hand knowledge of the industry, led Claudia to co-found ARENSIA Exploratory Medicine in Düsseldorf, Germany. Her primary aim is the contribution of innovative approaches to bring about substantial acceleration to the drug development process and enable more agile patient access to novel therapeutics.

Session Details:

Panel Discussion: Focusing on the patient: diversity, engagement and safety

2024-10-01, 5:00 PM

Session Details:

Why so slow? Insider insights from the clinic floor to speed up the startup and execution of proof-of-concept patient trials

2024-10-01, 11:30 AM

View In Agenda
Next speaker
Back
Lien Verheggen
Head of Clinical Operations. Estetra (a wholly owned subsidiary of Gedeon Richter Plc)

Session Details:

Panel Discussion: Defining effective governance structures and oversight models

2024-10-01, 12:00 PM

View In Agenda
Next speaker
Back
Sara Thuresson
Head of Clinical Operations, Guard Therapeutics

Session Details:

Panel Discussion: Defining effective governance structures and oversight models

2024-10-01, 12:00 PM

View In Agenda
Next speaker
Back
Joachim Lovin
DCT Specialist, Novo Nordisk

Joachim Lövin has worked in the pharmaceutical industry for over 20 years across various therapeutic areas and organizations. During this time, Joachim has worked in different roles spanning over Data Management, Project Management, Process Development, Senior Business Analyst and Clinical Operations. In his current role as DCT Specialist, Joachim focuses on supporting trials including competence development of Clinical Operations, identifying opportunities, and operationalising Decentralised Clinical Trial Elements across Novo Nordisk. Joachim is the Workstream Lead for the Modernizing Clinical Trial Conduct workstream for TransCelerate Biopharma, and a member of the eClinical Forums Trial of the Future. All of Joachim’s work is aligned with his passion to improve patient experience and accelerating clinical trials.

Session Details:

Implementing decentralised clinical trial (DCT) elements: a sponsor experience

2024-10-02, 12:00 PM

View In Agenda
Next speaker
Back
Anca Copaescu
Chief Executive Officer, Strategikon Pharma

Anca Copaescu, our CEO, is the powerhouse behind Strategikon's success and the driving force behind the company's revolutionary Clinical Maestro® platform.

With over 15 years of experience in the clinical research industry, Anca's expertise in clinical outsourcing and analytics is second to none. As Head of Clinical Outsourcing and Analytics at BioMarin Pharmaceuticals, she managed and advanced the company's global outsourcing, vendor management and clinical analytics functions.

Her passion for efficiency and innovation led her to relentlessly pursue improvements in clinical study planning, outsourcing, and financial management. And when she couldn't find a technology solution that met her standards, she decided to build a better one - the game-changing Clinical Maestro platform.

Session Details:

The new age of R&D procurement: clinical business operations transformed

2024-10-02, 11:30 AM

View In Agenda
Next speaker
Back
Kento Nakamura
Strategy and Corporate Development, CMIC

Kento Nakamura is a global professional having worked both in the Western and Eastern healthcare landscapes. He has been in various roles, contributing significantly to drug development, market access, and pharmaceutical marketing.

At CMIC, Japan and South Korea’s first CRO, Kento wears multiple hats including helping formulate corporate strategy, creating mutually beneficial partnerships with other companies, and taking initiative to create business development opportunities.

During his tenure at KM Pharmaceutical Consulting, a boutique drug development consulting firm, Kento co-pioneered the market access perspective on drug development, resulting in key additional endpoints in an ongoing phase 2 study. He also played a crucial role in developing the global drug safety plan, ensuring compliance with reporting requirements across multiple continents.

Kento holds an MPH in Health Management from Harvard University and a BS in Biology from Tufts University. He is fluent in English and proficient in Japanese. In his free time, Kento enjoys playing tennis, watching football, visiting contemporary art museums, and traveling around the world.

Session Details:

Asia Pacific clinical trials: opportunities and regulatory updates

2024-10-02, 9:30 AM

View In Agenda
Next speaker
Back
Asger Dahlgaard
VP of Quality Assurance and Regulatory Affairs, BioPorto Diagnostics A/S

Session Details:

ROUNDTABLE SESSIONS

2024-10-02, 3:00 PM

View In Agenda
Next speaker
Back
Scott Schliebner
Vice President Drug Development Consulting, Novotech

Scott is a strategic and innovative drug development executive with 30 years experience across the biopharma, CRO, and non-profit sectors.  Passionate about ensuring the patient voice is incorporated into drug development, Scott is focused on patient-focused innovations that reduce the burden of clinical trial.  With a particular focus on rare diseases, Scott has built partnerships and collaborations that have led to the acceleration of drug development for rare disease patients.  He received a Master’s Degree in Public Health in Biostatistics from the University of Utah School of Medicine and completed a Graduate Research Fellowship at The National Institutes of Health/NINDS.

Session Details:

Empowering patients to overcome challenges in orphan drug development

2024-10-01, 4:30 PM

View In Agenda
Next speaker
Back
Teske Valk
Lead Medical Project Manager, Novo Nordisk

Session Details:

Expert Conversation: Strategic Considerations for End-to-End Development of Fit-For-Purpose Digital Measures of Health

2024-10-02, 11:00 AM

View In Agenda
Next speaker
Back
Kai Langel
CEO, DEEP Measures

Session Details:

Expert Conversation: Strategic Considerations for End-to-End Development of Fit-For-Purpose Digital Measures of Health

2024-10-02, 11:00 AM

View In Agenda
Next speaker
Back
Rich Bennett
Senior Director, Therapeutic Strategy Lead, Neuroscience, Worldwide Clinical Trials

Richard Bennett is Senior Director and Therapeutic Strategy Lead in the Neuroscience franchise at Worldwide Clinical Trials. With two decades in the industry, he has advanced through the traditional clinical operations roles such as clinical research associate and clinical trial manager and has spent many years as a leader of clinical development programs in both the larger pharma and biotech setting. He has worked on neuromuscular disorders, rare diseases, critical care, pain and palliative care, dermatology, and epidemiology programs. His direct experience working with large pharma and small and emerging biotech firms has given him a deep understanding of the needs of our sponsors

Session Details:

Protocol optimization: How a transformational relationship with your CRO can increase your development programs’ chances of success

2024-10-01, 10:00 AM

View In Agenda
Next speaker
Back
Richard Gray
Managing Partner, Medidata, Dassault Systemes

Richard Gray is a Managing Partner at Dassault Life Sciences, engaged across the full portfolio including the market leading Medidata brand. He has been serving the life sciences & healthcare industry for over 30 years, inspired by the opportunity to accelerate productivity across the value chain and improve outcomes for patients.

With a background in process optimization, data, and technology, he has enabled many European and US sponsors to uplift their capabilities, and in his current role he is driving innovation in areas including early-stage research and discovery, through preclinical and clinical, out to manufacturing, supply chain and commercialisation.

Richard believes that data [strategy] holds the key to accelerating the value of technology, creating the opportunity to connect physical and digital worlds to advance virtual twin experiences, enabling the promise of AI to be democratized, and fueling in silico approaches that will revolutionise the science of tomorrow.

Session Details:

A new paradigm for clinical innovation

2024-10-01, 9:00 AM

Session Details:

Panel Discussion: Considering existing and emerging technology to assist with clinical trials

2024-10-02, 2:00 PM

View In Agenda
Next speaker
Back
Monika Martyka
Director Clinical Operations, TFS HealthScience

Monika Martyka has over 14 years of experience in clinical research and currently serves as Director of Clinical Operations at TFS HealthScience. She leads complex clinical projects, overseeing cross-functional teams, optimizing clinical processes, and ensuring alignment with regulatory standards. Monika excels in managing the intricacies of clinical trials, including protocol development, patient recruitment, and compliance, while driving operational efficiency to meet critical milestones.

Her expertise in both clinical and operational management has made her a key player in advancing healthcare through rigorous research methodologies. Dedicated to fostering collaboration and innovation, Monika is committed to the successful delivery of high-impact clinical trials that contribute to the development of cutting-edge therapies and improve patient outcomes globally.

Session Details:

Ensuring success: Essential sponsor oversight strategies for confirming your clinical study is on track

2024-10-01, 2:30 PM

View In Agenda
Next speaker
Back
Lina Gaggi
Product Manager, Viedoc

Lina Gaggi, Product Manager, has over 10 years' experience in computer engineering developing and delivering the products that customers want. With a keen eye for user needs, she knows how to find the right solution that reduces complexity and makes software enjoyable. Focusing on the life science industry at this stage in her career, she’s a dedicated product manager that can distill the big picture in order to find robust solutions for small tasks, that in the end deliver value to customers.

Session Details:

Reimagining clinical trials: Boosting efficiency with simplified, low-code builds

2024-10-02, 11:30 AM

View In Agenda
Next speaker
Back
Stine Friis Thorsen
Project Director, Evaxion Biotech

Session Details:

Building CRO Relationships: What are the critical factors to consider when procuring from a CRO?

2024-10-01, 11:00 AM

View In Agenda
Next speaker
Back
Benoit Cuyvers
Upstream AI Product Manager, Clario

Benoit Cuyvers is the Upstream AI (Artificial Intelligence) Product Manager for Clario, recently joining the team from the ArtiQ acquisition. (Leuven, Belgium). The acquisition advances our respiratory solutions portfolio, combining Clario’s deep scientific expertise with ArtiQ’s innovative artificial intelligence capabilities. Benoit led the efforts on the ArtiQ AI-enabled Risk Based Monitoring system, from concept to solution and will continue these endeavors in his role at Clario. With his background in Bioscience Engineering and his past experience as a digital health expert at Siemens, Benoit is able to apply learnings from other medical and technical fields to the field of AI in respiratory research & medicine.

Session Details:

AI in Risk Based (Quality) Monitoring

2024-10-02, 9:30 AM

View In Agenda
Next speaker
Back
Chloe Gower-Page
Senior Account Director, Site Engagement, Clinical Trial Experience, Langland

Chloe has spent the last 10 years working within healthcare communications, gaining experience across advertising, medical strategy and education and clinical trials. Her experience spans the full product lifecycle, from protocol review and early phase clinical trials through product launch and then lifecycle management. Through this she has worked with a broad stakeholder group including marketing, medical affairs, clinical development and operations, market access and field force teams, as well as with small, medium and big pharma.

Chloe is a strategic thinker and loves partnering closely with her clients to really understand their challenge. She is skilled at bringing in the right expertise at the right time to enable her clients to think further about the work they are doing, innovate when needed and ultimately deliver for the best outcomes for patients. In her current role, Chloe provides strategic leadership to her clients across a range of site engagement activities, from standalone IMs through to broader strategic communication planning for sites. She is passionate about creating programmes that allow true collaboration between site and sponsor, enabling studies to perform well and build relationships that last beyond the end of a single study.

Chloe has worked across a number of therapy areas with extensive experience in rare disease, oncology, ophthalmology and gastroenterology. Prior to working within healthcare communications, Chloe gained a degree in Human Biology from the University of Birmingham and further training in Human Nutrition.

Session Details:

Lessons in chemistry: The art of site engagement

2024-10-01, 12:30 PM

View In Agenda
Next speaker
Back
Révérien Uwacu
Clinical Trial Supply Management Consultant at UCB

Originally from Rwanda but studied and living in Belgium, Reverien has an IT and Supply Chain academic background. Professionally, he is a pharma Supply Chain Consultant with 12+years’ experience. Reverien’s experience includes companies such as Johnson and Johnson, UCB, Baxter, and Thermofisher.

Session Details:

Panel Discussion: Focusing on the patient: diversity, engagement and safety

2024-10-01, 5:00 PM

View In Agenda
Next speaker
Back
Pernille Hemmingsen
Chief Technology Officer, Adcendo

Pernille Hemmingsen has more than a decade of experience in the development of pharmaceutical products. With a background in biophysical chemistry and chemical engineering, she is particularly interested in the development of robust manufacturing methods and solid quality to enable the best patient experience and convenience. This interest has led to the development of products ranging from cancer targeting liposomes and antibody drug conjugates to tamper resistant tablets and enhanced diabetes formulations at companies including Genmab and Novo Nordisk. Currently, Pernille Hemmingsen is responsible for the chemistry, manufacturing and control at Adcendo, taking to role as CTO. This work particularly includes establishing an efficient supply chain that encompasses elements from both biologics and small molecules. Pernille holds a Ph.D. from the Department of Chemistry at the Technical University of Denmark and an executive Master of Business Administration from Copenhagen Business School.

Session Details:

ROUNDTABLE SESSIONS

2024-10-02, 3:00 PM

View In Agenda
Next speaker

OCT Advisory Board

Select a member to learn more

Back
Rosalie Filling
Vice President, Senior Global Head R&D Operations, Endo Pharmaceuticals

In her over 25 years of experience, Rosalie “Rosie” Filling has transformed R&D operations in every company she has worked for, developing clear-cut strategies to help advance clinical trials with high-quality operational execution and scientific excellence.

 

Rosie is the Vice President, Senior Global Head R&D Operations Endo International plc. She is part of the global R&D leadership team and is charged with the coordination and implementation of clinical development strategies for the company’s research and development. She provides strategic direction and oversight of the R&D Operations team, which includes clinical operations, data management, biostatistics, medical writing, clinical supplies, trial master file/inspection readiness and business operations. This integrated team handles the execution of all aspects related to Endo’s clinical trials. Endo has active research and development programs in men’s health, orthopedics, and endocrinology. Beyond these therapeutic areas, the company also has focused development in the areas of sterile injectables and complex generic products.

 

Rosie’s main focus at all times is on the end users—the patients. Bringing new and, at times, life-saving medications to patients drives Rosie’s sense of purpose.

 

Rosie joined Endo from Lupin Pharmaceuticals in Blue Bell, PA where she was Senior Director, Head of Clinical Operations, and built the clinical operations organization to support the US and Global R&D Organization. Prior to Lupin, Rosie spent nearly five years at Teva in Frazer, PA where she was the US site head of Clinical Operations and was responsible for the successful delivery of Inhalation, Women’s Health, and Cardiovascular clinical trials. Earlier in her career, Rosie held various roles at Eisai, MGI Pharma and PPD.

 

Rosie earned her B.S. in Biology with a minor in Chemistry from the University of Pittsburgh.

Next
Back
Kathleen Cohen
Vice President, Clinical Development, Marinus Pharmaceuticals

Kathleen Frenia Cohen is Vice President and Head of Clinical Development Operations at Marinus Pharmaceuticals.  Prior to joining Marinus, she spent 20+ years at PRA Health Sciences in a variety of project management and operational oversite roles. Kathleen graduated from the University of the Science in Philadelphia with a PharmD and completed a post-doctoral fellowship in Pharmacoeconomics and Outcomes Research from Rutgers College of Pharmacy. Kathleen resides in Media, PA.

Next
Back
THOMAS M TREMBLAY
Vice President Of Clinical Development, Trefoil Therapeutics, Inc

Thomas is a registered nurse with both clinical and over 30 years pharmaceutical development experience. His pharmaceutical development experience includes clinical operations, clinical science, clinical development, drug safety and quality. He is currently Vice President of Clinical Development at Trefoil Therapeutics and adjunct faculty at San Francisco State University.

Next
Back
Behtash Bahador
Director, Health Literacy, CISCRP

Behtash Bahador is the Director of Health Literacy at the non-profit organization CISCRP, and holds a Master of Science in Health Communication from the Tufts University School of Medicine. Since 2014, he has collaborated with a range of stakeholder groups to establish and implement patient- and public-centric initiatives across the life-cycle of drug and treatment development. This has included supporting the development of regulatory and cross-disciplinary best practice guidelines, operationalizing key elements of evidence-based public health programing into research engagement activities, and always keeping the needs of patients, participants and the public at the forefront of his work.

Next

Plan Your Visit

Venue

Clarion Hotel & Congress Copenhagen Airport

Clarion Hotel & Congress Copenhagen Airport, Kastrup,Denmark, 2770

Accommodation

Arena International Events Group “(Arena”) is aware of numerous third party agencies which are contacting Arena’s customers and purporting to have access to hotel room bookings and events attendee lists. For the avoidance of doubt, Arena will only share attendee lists with carefully selected third party partners for event registration purposes. Whilst Arena International Events Group pursues third party agencies for their potentially illicit activity, Arena encourages you to be cautious in engaging with such third party agencies and Arena shall not accept any responsibility for any losses incurred by you should you choose to engage with third parties that have no affiliation to Arena International Events Group.

Sponsors

Select a sponsor to learn more

FEATURED SPONSORS

SESSION SPONSORS

TECHNOLOGY SHOWCASE SPONSOR

DRINKS RECEPTION

REGISTRATION SPONSOR

EXHIBITOR

CO-SPONSOR

Why partner?

 

Contact us to become a partner

Partnership Opportunities

We work with you to design a bespoke package to meet your business needs, where you could:

  • Demonstrate your expertise on the agenda – have the attention of the entire audience. For greatest impact, why not position your talk before a networking break and immediately conduct follow up conversations with highly engaged attendees
  • Showcase your business and its services at an exhibition booth, which provides a perfect meeting place for prospective new clients
    Present the value proposition of your offering over your competitors, in front of an audience of active, engaged potential customers
  • Speak with key decision makers as part of our intimate, interactive roundtable style workshop sessions with over 8 hours allowed for networking

Event reach

  • 200+ attendees each year
  • 80% attendees C-suite level

 

Take a look at our current sponsors

Media Centre

MEDIA PARTNERS

Become A Media Partner

Enquiry

Contact Us

SPONSORSHIP ENQUIRIES

Alex Purnell

Senior Sponsorship Manager

+44 204540 7786

SPEAKER ENQUIRIES

Ruth Atterbury

Portfolio Manager

+44 (0) 20 4540 7796

MARKETING ENQUIRIES

Moona Popal

Marketing Manager

DELEGATE ENQUIRIES

Sunny Saikia

VIP Delegate Manager

SPONSORSHIP ENQUIRIES

To enquire about sponsorship opportunities for the conference, please contact:

Alex Purnell

Senior Sponsorship Manager


+44 204540 7786

SPEAKER ENQUIRES

To enquire about speaking opportunities for the conference, please contact:

Ruth Atterbury

Portfolio Manager


+44 (0) 20 4540 7796